Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 7/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.49 |
| ▸ | HCAR1 | Q9BXC0 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | MGLL | Q99685 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12692935 | 0.81 | HSP90AA1 (0.57) | HSP90AA1CYP1A2HCAR1L3MBTL1POLB | |
| SCHEMBL14422963 | 0.79 | TDP1 (0.73) | TDP1RAB9AALDH1A1SMN1; SMN2 | |
| SCHEMBL3520528 | 0.77 | L3MBTL1 (0.66) | CYP1A2HCAR1L3MBTL1POLBTDP1 | |
| SCHEMBL7017759 | 0.76 | CYP1A2 (0.43) | HSP90AA1CYP1A2L3MBTL1POLBTDP1 | |
| SCHEMBL5821201 | 0.76 | MAPK9 (0.58) | HSP90AA1TDP1ALDH1A1 | |
| SCHEMBL1133466 | 0.74 | TDP1 (0.66) | CYP1A2L3MBTL1POLBTDP1NPC1 | |
| SCHEMBL3307780 | 0.72 | HSP90AA1 (0.48) | HSP90AA1L3MBTL1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL10811779 | 0.71 | GAA (0.52) | HSP90AA1HCAR1POLBMGLLALDH1A1 | |
| SCHEMBL15545763 | 0.70 | L3MBTL1 (0.59) | CYP1A2L3MBTL1POLBTDP1NPC1 | |
| SCHEMBL30939521 | 0.70 | L3MBTL1 (0.59) | CYP1A2L3MBTL1POLBTDP1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110168543-A1 | Microwave-Assisted Synthesis of Perfluorophthalocyanine Molecules | NEW JERSEY INSTITUTE OF TECHNOLOGY (US) | 2011-07-14 | — | — | US | disclosed |
| US-20110172437-A1 | Perfluorophthalocyanine Molecules and Methods of Synthesis | NEW JERSEY INSTITUTE OF TECHNOLOGY (US) | 2011-07-14 | — | — | US | disclosed |
| EP-2285909-A1 | PERFLUOROPHTHALOCYANINE MOLECULES AND METHODS FOR SYNTHESIS | New Jersey Institute of Technology (US) | 2011-02-23 | — | — | EP | disclosed |
| EP-2285907-A1 | MICROWAVE-ASSISTED SYNTHESIS OF PERFLUOROPHTHALOCYANINE MOLECULES | New Jersey Institute of Technology (US) | 2011-02-23 | — | — | EP | disclosed |
| WO-2009148693-A1 | PERFLUOROPHTHALOCYANINE MOLECULES AND METHODS FOR SYNTHESIS | NEW JERSEY INSTITUTE OF TECHNOLOGY (US) | 2009-12-10 | — | — | WO | disclosed |
| WO-2009139973-A1 | MICROWAVE-ASSISTED SYNTHESIS OF PERFLUOROPHTHALOCYANINE MOLECULES | NEW JERSEY INSTITUTE OF TECHNOLOGY (US) | 2009-11-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110172437-A1 | Perfluorophthalocyanine Molecules and Methods of Synthesis | PICALM, PFKFB3, FOS | HSP90AA1 4328/4885CYP1A2 751/4885HCAR1 4392/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.